Abstract
Taxol is a promising antitumor agent with poor water solubility. Intravenous administration of a current taxol formulation in a non-aqueous vehicle containing Cremophor EL may cause allergic reactions and precipitation upon aqueous dilution. In this study a novel approach to formulate taxol in aqueous medium for i.v. delivery is described. The drug is solubilized in bile salt (BS)/phospholipid (PC) mixed micelles. The solubilization potential of the mixed micelles increased as the total lipid concentration and the molar ratio of PC/BS increased. Precipitation of the drug upon dilution was avoided by the spontaneous formation of drug-loaded liposomes from mixed micelles. The formulation can be stored in a freeze-dried form as mixed micelles to achieve optimum stability, and liposomes can be prepared by simple dilution just before administration. As judged by a panel of cultured cell lines, the cytotoxic activity of taxol was retained when formulated as a mixed-micellar solution. Further, for the same solubilization potential, the mixed-micellar vehicle appeared to be less toxic than the standard nonaqueous vehicle of taxol containing Cremorphor EL.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
M. C. Wani, H. L. Taylor, M. E. Wall, et al. Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. J. Am. Chem. Soc. 93:2325–2327 (1971).
A. I. Einzig, P. H. Wiernik, and E. L. Schwartz. Taxol: A new agent active in melanoma and ovarian cancer. In M. Muggia (eds.), New Drugs, Concepts and Results in Cancer Chemotherapy, Kluwer Academic, Boston, 1991.
P. B. Schiff and S. B. Horwitz. Taxol stabilizes microtubule in mouse fibroblast cells. Proc. Natl. Acad. Sci. USA 77:1561–1565 (1980).
J. Parness and S. B. Horwitz. Taxol binds to polymerized tubulin in vitro. J. Cell Biol. 91:479–487 (1981).
J. N. Denis and A. E. Greene. A highly efficient practical approach to natural taxol. J. Am. Chem. Soc. 110:5917–5919 (1988).
NCI Investigational Drugs. Pharmaceutical data, 1990, pp. 151–152.
M. Lassus, D. Scott and J. B. Leyland. Allergic reactions associated with cremophor containing antineoplastics. Proc. Am. Soc. Clin. Oncol. 4:268 (1985).
S. M. Edgington. Taxol out of the woods. Bio/Technology 9:933–938 (1991).
B. D. Tarr, T. G. Sambandan, and S. H. Yalkowsky. A new parenteral emulsion for the administration of taxol. Pharm. Res. 4:162–165 (1987).
M. H. Bartoli, M. Biotard, H. F. Fessi, et al. In-vitro and in vivo antitumoral activity of free, and encapsulated taxol. J. Microencapsul. 7:191–197 (1990).
K. Son and M. H. Alkan. Liposomes prepared dynamically by interactions between bile salt and phospholipid molecules. Biochim. Biophys. Acta 981:288–294 (1989).
H. Alkan-Onyuksel and K. Son. Mixed micelles as proliposomes for the solubilization of teniposide. Pharm. Res. 9:1556–1562 (1992).
D. W. Shen, A. Fojo, J. E. Chin, et al. Human multidrug-resistant cell lines: Increased mdrl expression can precede gene amplification. Science 232:643–645 (1986).
K. Likhitwitayawuid, C. K. Angerhofer, N. Ruangrungsi, G. A. Cordell, and J. M. Pezzuto. Cytotoxic and antimalarial bisbenzylisoquinoline alkaloids from Stephania erecta. J. Natl. Prod. 56:30–38 (1993).
J. T. Litchfield, Jr., and F. Wilcoxon. A simplified method of evaluating dose-effect experiments. J. Pharmacol. Exp. Ther. 96:99–113 (1949).
R. P. Hjelm, P. Thiyagarajan, and H. Alkan. A small angle neutron scattering study of the effects of dilution on particle morphology in mixtures of glycocholate and lecithin. J. Appl. Cryst. 21:858–863 (1988).
R. P. Hjelm, P. Thiyagarajan, and H. Alkan-Onyuksel. Organization of phosphatidycholine and bile salt in rodlike mixed micelles. J. Phys. Chem. 96:8653–8661 (1992).
N. A. Mazer, G. B. Benedek, and M. C. Carey. Quasielastic light scattering studies of aqueous bilayer lipid systems. Biochemistry 19:601–615 (1980).
P. Schurtenberger, N. A. Mazer, and W. Kanzig. Micelle to vesicle transition in aqueous solutions of bile salt and lecithin. J. Phys. Chem. 89:1042–1049 (1985).
K. Son. Detergent and Phospholipid Mixed Micelles as Proliposomes for an Intravenous Delivery of Water Insoluble Drugs. Ph.D. thesis, University of Illinois at Chicago, Chicago, 1991.
S. C. Su, M. H. Alkan, J. Y. Park, et al. Mesophase formation during in vitro cholesterol gallstone dissolution. J. Pharm Sci. 70:713–715 (1981).
E. S. Swenson and W. J. Curatolo. Intestinal permeability enhancement for proteins, peptides and other polar drugs: Mechanism and potential toxicity. Adv. Drug. Del. Rev. 8:39–92, (1992).
K. Teelmann, B. Schlappi, M. Schupbach, and A. Kistler. Preclinical safety evaluation of intravenously administered mixed micelles. Drug Res. 34:1517–1523 (1984).
G. A. Cordell, C. C. W. Beecher, and J. M. Pezzuto. Can ethnopharmacology contribute to the development of new anticancer drugs? J. Ethnopharmacol 32:117–133 (1991).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Alkan-Onyuksel, H., Ramakrishnan, S., Chai, HB. et al. A Mixed Micellar Formulation Suitable for the Parenteral Administration of Taxol. Pharm Res 11, 206–212 (1994). https://doi.org/10.1023/A:1018943021705
Issue Date:
DOI: https://doi.org/10.1023/A:1018943021705